Can people with blepharitis receive the 13-valent pneumococcal vaccine?

Patients with blepharitis can receive the 13-valent pneumococcal vaccine, as there is no direct contraindication between the two conditions. Blepharitis is a localized inflammation of the eyelid margins, while the 13-valent pneumococcal vaccine primarily works through the systemic immune system to prevent infections caused by Streptococcus pneumoniae. Localized inflammation like blepharitis is not an absolute contraindication for vaccination. However, it is important to ensure that the inflammation is not in an acute flare-up phase before vaccination. If there are any concerns, consultation with a healthcare professional is recommended.

The affected area in blepharitis is limited to the eyelid margin and is commonly caused by bacterial infection or abnormal sebum secretion. It does not constitute a systemic severe infection or serious immune dysfunction, and therefore does not interfere with the vaccine's immunogenicity or increase the risk of adverse reactions following vaccination. However, if blepharitis is in an acute phase—accompanied by obvious symptoms such as redness, swelling, pain, or pus—it is advisable to first control the inflammation before receiving the vaccine, to avoid confusion between inflammatory symptoms and mild post-vaccination reactions.

After vaccination, attention should be paid to eye care: keep the eyelid margins clean and dry, avoid rubbing the eyes with hands, and minimize bacterial growth. In terms of diet, avoid spicy and irritating foods, drink plenty of water, and support the body’s metabolism. Also monitor the injection site for discomfort such as redness or pain, and observe whether any eye symptoms change. Proper daily care will help the body recover smoothly.